Search
for
Sort by
Research 331–360 of 554
- Delivery Strategies of siRNA Therapeutics for Hair Loss Therapy
- Case Report: Alopecia areata in an adolescent after COVID-19 infection
- Successful Remission of Alopecia Areata and Seborrheic Dermatitis in a 21-Year-Old Male via Functional Nutrition and Advanced Diagnostics: A Case Report.
- Network pharmacology, molecular docking, and dynamics reveal the mechanisms of Hejie Shengfa Decoction against alopecia areata
- Irish dermatologists’ experience with JAK inhibitors in alopecia areata
- Insights into the Diagnostics and Therapeutics of Alopecia Areata—An Indian Context
- The Safety and Efficacy of a Proprietary Bioactive Fatty Acids Extract From Saw Palmetto ( <i>Serenoa repens</i> ) for Promoting Hair Growth and Reducing Hair Loss in Adults With Self‐Perceived Thinning Hair: 90‐Day Results
- When JAK inhibitors are off the table: durable remission of severe alopecia areata with dexamethasone oral mini-pulse and a focused review
- “<i>Nomen Omen</i>: The Myth of God Janus”
- Caffeine Supplementation and Hair: A Systematic Review
- Criteria for Commencing and Continuing Subsidised Janus Kinase Inhibitor Therapy in Australian Alopecia Areata Patients—Results From an Australian Expert Consensus Exercise
- Is Intralesional Methotrexate an Effective Alternative to Intralesional Triamcinolone in Alopecia Areata? Findings From a Randomized Controlled Trial
- 0433 JAK inhibitor halts the progression of acute exacerbation of alopecia areata
- Etrasimod for alopecia areata: The scenario for a less extensive and moderate form
- Efficacy and Safety of Long‐Term Azathioprine Therapy for Severe Alopecia Areata: A 10‐Year Cohort Study
- Real-world Effectiveness and Safety of Janus Kinase Inhibitors in Alopecia Areata: A Retrospective Cohort Study of 72 Patients
- The Use of Janus Kinase Inhibitors for Primary Neutrophilic Cicatricial Alopecias
- Efficacy, safety and tolerability of drugs for alopecia: a comprehensive review
- Wiederbehaarung bei einem Patienten mit Alopecia universalis und Psoriasis vulgaris unter Deucravacitinib‐Therapie
- Pediatric and Adolescent Alopecia Areata Treated with JAK Inhibitors: Balancing Efficacy and Safety Across Clinical Trials
- Hair regrowth in a patient with alopecia universalis and psoriasis vulgaris during deucravacitinib therapy
- In vitro hair growth-promoting effects of araliadiol via the p38/PPAR-γ signaling pathway in human hair follicle stem cells and dermal papilla cells
- Prescribing patterns amongst UK dermatologists for the treatment of alopecia areata, female pattern hair loss, and frontal fibrosing alopecia
- Efficacy and Tolerability of Brevilin-A, a Natural JAK Inhibitor, in Pediatric Alopecia Areata: A Case Series
- Small Molecule Agents Against Alopecia: Potential Targets and Related Pathways
- Growth Factors and Microneedling in Alopecia Areata: A Narrative Review
- Evaluation of the Efficacy and Safety of Oral Tofacitinib for the Treatment of Alopecia Areata in Children
- A diagnostic clue: New onset alopecia sparing white hairs
- 69 Risk-benefit appraisal of systemic JAK inhibitors for alopecia areata: a comprehensive meta-analysis assessing safety and adverse effects
- Screening for latent infectious disease in patients with alopecia areata before initiating JAK inhibitors therapy: a single-center real-world retrospective study